SAN DIEGO (AP) _ Conatus Pharmaceuticals Inc. (CNAT) on Wednesday reported a loss of $5.3 million in its fourth quarter.
On a per-share basis, the San Diego-based company said it had a loss of 34 cents.
For the year, the company reported profit of $22.3 million, or $1.44 per share.
Conatus shares have decreased 19 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $5.66, a drop of 54 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CNAT at http://www.zacks.com/ap/CNAT
Keywords: Conatus Pharmaceuticals, Earnings Report